<SEC-DOCUMENT>0001564590-22-010864.txt : 20220317
<SEC-HEADER>0001564590-22-010864.hdr.sgml : 20220317
<ACCEPTANCE-DATETIME>20220317160718
ACCESSION NUMBER:		0001564590-22-010864
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220317
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220317
DATE AS OF CHANGE:		20220317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Trevi Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001563880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450834299
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38886
		FILM NUMBER:		22748555

	BUSINESS ADDRESS:	
		STREET 1:		195 CHURCH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510
		BUSINESS PHONE:		203-304-2499

	MAIL ADDRESS:	
		STREET 1:		195 CHURCH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>trvi-8k_20220317.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-17T15:51:06.3516404+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 00a6edb0ee1c494c9c06a5b6abb60fa0 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:trvi="http://www.trevitherapeutics.com/20220317" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
trvi-8k_20220317.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000000" name="dei:AmendmentFlag" contextRef="C_0001563880_20220317_20220317">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000001" name="dei:EntityCentralIndexKey" contextRef="C_0001563880_20220317_20220317">0001563880</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="trvi-20220317.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001563880_20220317_20220317">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001563880</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-03-17</xbrli:startDate>
					<xbrli:endDate>2022-03-17</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549 </p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000002" name="dei:DocumentType" contextRef="C_0001563880_20220317_20220317">8-K</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) of </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of report (Date of earliest event reported): <ix:nonNumeric id="F_000003" name="dei:DocumentPeriodEndDate" contextRef="C_0001563880_20220317_20220317" format="ixt:datemonthdayyearen">March 17, 2022</ix:nonNumeric> </p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000004" name="dei:EntityRegistrantName" contextRef="C_0001563880_20220317_20220317">Trevi Therapeutics,&#160;Inc.</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact Name of Registrant as Specified in Charter) </p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0001563880_20220317_20220317">001-38886</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001563880_20220317_20220317">45-0834299</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Incorporation)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS&#160;Employer</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification&#160;No.)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityAddressAddressLine1" contextRef="C_0001563880_20220317_20220317">195 Church Street</ix:nonNumeric>, <ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine2" contextRef="C_0001563880_20220317_20220317">14<span style="font-size:8.5pt;">th</span> Floor</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityAddressCityOrTown" contextRef="C_0001563880_20220317_20220317">New Haven</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressStateOrProvince" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:stateprovnameen">Connecticut</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000012" name="dei:EntityAddressPostalZipCode" contextRef="C_0001563880_20220317_20220317">06510</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric id="F_000013" name="dei:CityAreaCode" contextRef="C_0001563880_20220317_20220317">(203)</ix:nonNumeric> <ix:nonNumeric id="F_000014" name="dei:LocalPhoneNumber" contextRef="C_0001563880_20220317_20220317">304-2499</ix:nonNumeric></p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Not applicable </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former Name or Former Address, if Changed Since Last Report) </p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000015" name="dei:WrittenCommunications" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:SolicitingMaterial" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:PreCommencementTenderOffer" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%; border-bottom:solid 1pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">symbol(s)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">on which registered</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:Security12bTitle" contextRef="C_0001563880_20220317_20220317">Common stock, $0.001 par value per share</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:TradingSymbol" contextRef="C_0001563880_20220317_20220317">TRVI</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:SecurityExchangeName" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </p>
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000022" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span> </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000023" name="dei:EntityExTransitionPeriod" contextRef="C_0001563880_20220317_20220317" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span> </p>
<p style="border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.02 Results of Operations and Financial Condition </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 17, 2022, Trevi Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;) announced its financial results for the quarter and year ended December&#160;31, 2021. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information provided under Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01. Financial Statements and Exhibits. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:8.36%; border-bottom:solid 1pt transparent;white-space:nowrap;">
<p style="border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit&#160;No.</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.06%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90.56%; border-bottom:solid 1pt #000000;">
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:90.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="trvi-ex991_6.htm"><span style="text-decoration:underline;">Press release issued by the Company on March 17, 2022*</span></a></p></td>
</tr>
<tr style="height:4.95pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The exhibit shall be deemed to be furnished, and not filed. </p></td></tr></table></div>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TREVI THERAPEUTICS,&#160;INC.</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 17, 2022</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:10%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:42%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Lisa Delfini</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Lisa Delfini</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>trvi-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
trvi-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3zsz0wdgmtp000001.jpg" title="" alt="" style="width:216px;height:129px;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Trevi Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Business Update </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Interim Analysis in Phase 2 CANAL Trial Showed Primary Efficacy Endpoint of Cough Reduction in Idiopathic Pulmonary Fibrosis was Highly Statistically Significant (p-value less than 0.0001)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Enrollment Ended Early</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Trevi to host a KOL call &#8220;Understanding the Seriousness of Chronic Cough in IPF Patients&#8221; on March 30, 2022, from 8:00 to 9:00 am EDT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Phase 2b/3 PRISM Trial (Chronic Pruritus in PN) Completed Enrollment </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Top-Line Data Readout Expected Second Quarter of 2022 </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Management to Host Conference Call and Webcast Today at 4:30 p.m. EDT </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">New Haven, Conn., March 17, 2022<font style="font-weight:normal;"> &#8211; Trevi Therapeutics, Inc. (Nasdaq: TRVI) is a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio&#8482; (nalbuphine ER). Today, Trevi announced financial results for the quarter and year ended December&#160;31, 2021, as well as provided business updates. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;We have made considerable progress on our two development programs with positive interim analysis results from our Phase 2 CANAL study for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and the completion of enrollment in our Phase 2b/3 PRISM study for the treatment of pruritus due to prurigo nodularis (PN),&#8221; said Jennifer L. Good, President and CEO of Trevi Therapeutics. &#8220;We were very pleased to see the strong magnitude of response and consistent results of Haduvio in the interim analysis for chronic cough in IPF. These results further support our belief in the overall mechanism of Haduvio and the potential to treat both chronic cough and chronic pruritus in various conditions. Chronic cough in IPF and pruritus in PN are both serious and debilitating conditions with no currently approved therapies and each of them potentially represents a significant opportunity to address an unmet need in the market.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Key Business Updates</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:11pt;color:#000000;">Positive interim analysis results from the Phase 2 CANAL trial of Haduvio for chronic cough in patients with IPF</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.19%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">The interim analysis was statistically significant on the primary endpoint demonstrating a 52% placebo-adjusted reduction in the geometric mean percent change in daytime cough events (p&lt;0.0001) for Haduvio</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.19%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Due to the magnitude of response in the interim analysis, enrollment concluded early and top-line data for the full set of approximately 40 subjects is expected in the third quarter of 2022</font></p></td></tr></table></div>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.93%;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:11pt;color:#000000;">Phase 2b/3 PRISM trial of Haduvio for severe pruritus in patients with PN</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.19%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Completed enrollment on January 31, 2022 </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.19%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Top-line data readout expected in the second quarter of 2022</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Fourth Quarter 2021 Financial Highlights</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Research and development (R&amp;D) expenses: <font style="font-weight:normal;">R&amp;D expenses for the fourth quarter of 2021 were $6.2 million compared to $6.6 million in the same period in 2020. The decrease was primarily due to decreased purchases of clinical trial supplies. This decrease was partially</font><font style="color:#000000;font-weight:normal;"> offset by increased activity in the Company&#8217;s Phase 2 CANAL clinical trial as well as an increase in personnel-related expenses due to increased employee headcount. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">General and administrative (G&amp;A) expenses: <font style="font-weight:normal;">G&amp;A expenses for the fourth quarter of 2021 were $2.1 million compared to $2.6 million in the same period in 2020. The decrease was primarily due to decreased market research costs.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Net loss: <font style="font-weight:normal;">For the fourth quarter of 2021, the Company reported a net loss of $8.5 million, compared to a net loss of $9.5 million in the same period in 2020. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Year End 2021 Financial Highlights</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Cash position: <font style="font-weight:normal;">As of December 31, 2021, the Company had total cash and cash equivalents of $36.8<strike> </strike>million. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D expenses:<font style="font-weight:normal;">&#160;R&amp;D expenses for the year ended&#160;December 31, 2021&#160;were&#160;$23.0 million&#160;compared to&#160;$22.3 million&#160;for the year ended&#160;December 31, 2020. The increase was primarily due to an increase in personnel-related expenses due to increased employee headcount, including a related increase in stock-based compensation. Costs associated with clinical trials also increased along with consulting and professional fees. These increases were partially offset by decreased purchases of clinical trial supplies. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">G&amp;A expenses:<font style="font-weight:normal;">&#160;G&amp;A expenses for the year ended&#160;December 31, 2021&#160;were&#160;$9.5 million&#160;compared to&#160;$10.2 million&#160;for the year ended&#160;December 31, 2020. The decrease was primarily due to decreased market research costs as well as lower stock-based compensation expense as a result of employee turnover, which was partially offset by higher legal and other professional fees.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Net loss:<font style="font-weight:normal;">&#160;For the year ended&#160;December 31, 2021,&#160;Trevi&#160;reported a net loss of&#160;$33.9 million&#160;compared to a net loss of&#160;$32.8 million&#160;for the year ended&#160;December 31, 2020.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Conference Call</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To participate in the live conference call by phone, please dial (888) 317 6003 (domestic) or (412) 317 6061 (international) and provide access code 9674297. A live audio webcast will be accessible from the &#8216;Investors &amp; News&#8217; section on the Company&#8217;s website at&#160;www.trevitherapeutics.com. An archived replay of the webcast will also be available for 30 days on the Company&#8217;s website following the event.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Upcoming Meetings</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company plans to present at the following upcoming conferences and events: </p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">March 30, 8:00 a.m. &#8211; 9:00 a.m. ET: &#8220;Understanding the Seriousness of Chronic Cough in IPF Patients and Trevi&#8217;s Latest Data.&#8221; A webinar featuring Trevi management, along with insights from an IPF expert.</font></p></td></tr></table></div>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.73%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="text-decoration:none;Background-color:#auto;font-size:11pt;font-family:'Times New Roman';"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">April 1</font><font style="font-size:11pt;color:#000000;">2, 8:00</font><font style="font-size:11pt;color:#000000;"> </font><font style="font-size:11pt;color:#000000;">&#8211; 8:45 am Fireside Chat</font><font style="font-size:11pt;color:#000000;">:</font><font style="font-size:11pt;color:#000000;"> </font><font style="font-size:11pt;color:#000000;"> 21</font><font style="font-size:11pt;color:#000000;"><sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup></font><font style="font-size:11pt;color:#000000;"> Annual Needham Virtual Healthcare Conference</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">About&#160;Trevi Therapeutics, Inc.<font style="font-size:12pt;font-weight:normal;"><br /></font><font style="font-weight:normal;">Trevi Therapeutics, Inc.&#160;is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio to treat serious neurologically mediated conditions.&#160;Trevi&#160;is conducting a Phase&#160;2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Founded in 2011,&#160;Trevi Therapeutics&#160;is headquartered in&#160;New Haven, CT.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">About Haduvio<font style="font-weight:normal;"><br />Haduvio, an investigational therapy, is an oral extended-release (ER) formulation of nalbuphine. Nalbuphine is a mixed &#312;-opioid receptor agonist and &#181;-opioid receptor antagonist that has been approved and marketed as an injectable for pain indications for more than 20 years in&#160;the United States&#160;and&#160;Europe. The &#312;- and &#181;-opioid receptors are known to be critical mediators of itch, cough and certain movement disorders. Nalbuphine's mechanism of action may also mitigate the risk of abuse associated with &#181;-opioid agonists because it antagonizes, or blocks, &#181;-opioid receptors. Parenteral nalbuphine is not currently classified as a controlled substance by the DEA in&#160;the United States&#160;or by regulatory authorities in most of&#160;Europe.&#160;Trevi&#160;intends to propose Haduvio as the trade name for nalbuphine ER. Nalbuphine ER (Haduvio) is an investigational therapy that has been granted Fast Track designation by the FDA for the proposed indication of reduction of moderate to severe pruritus in patients with prurigo nodularis. Its safety and efficacy have not been evaluated by any regulatory authority.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Forward-Looking Statements<font style="font-weight:normal;"><br />Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the expected timing of reporting top-line data from Trevi's Phase 2b/3 PRISM trial of Haduvio in subjects with PN and the expected timing of reporting top-line data from the full set of subjects&#8217; data from Trevi&#8217;s Phase 2 CANAL trial of Haduvio in IPF subjects with chronic cough; Trevi's business plans and objectives, including future plans or expectations for Trevi's product candidates; expectations regarding Trevi's uses and sufficiency of capital; and other statements containing the words "believes," "anticipates," "plans," "expects," and similar expressions. Risks that contribute to the uncertain nature of the forward-looking statements include: uncertainties regarding the success, cost and timing of Trevi's product candidate development activities and ongoing and planned clinical trials, including with respect to the timing of reporting top-line data from both Trevi&#8217;s Phase 2b/3 PRISM trial and Phase 2 CANAL trial; uncertainties regarding Trevi's ability to execute on its strategy; the risk that positive interim or top-line results from a clinical trial may not necessarily be predictive of the results of the completed trial or other future or ongoing clinical trials; potential regulatory developments in the United States and foreign countries; uncertainties regarding fast track designation and the effect such status could have on the regulatory review or approval process; uncertainties inherent in estimating Trevi's cash runway, future expenses and other financial results, including Trevi's ability to continue as a going concern, comply with its obligations under its loan facility and fund future operations; uncertainties regarding Trevi&#8217;s ability to maintain its listing on the Nasdaq Global Market; uncertainties regarding the scope, timing and severity of the COVID-19 pandemic, the impact of the COVID-19 pandemic on Trevi's clinical operations and actions taken in response to the pandemic; as well as other risks and uncertainties set forth in the quarterly report </font></p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;">on Form 10-</font><font style="font-weight:normal;">Q</font><font style="font-weight:normal;"> for the quarter ended </font><font style="font-weight:normal;">September </font><font style="font-weight:normal;">3</font><font style="font-weight:normal;">0</font><font style="font-weight:normal;">, 2021 filed with the Securities and Exchange Commission and in subsequent filings with the Securities and Exchange Commission.&nbsp;&nbsp;All forward-looking statements contained in this press release speak only as of the date on which they were made. Trevi undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Trevi Therapeutics, Inc. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Selected Balance Sheet Data</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">(unaudited)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">(amounts in thousands) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,830</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,001</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Working capital</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,233</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,714</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,475</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,131</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,485</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,954</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders' equity</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,075</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,282</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Trevi Therapeutics, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Selected Statement of Operations Data </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">(unaudited)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">(amounts in thousands, except per share amounts)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Year Ended</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,178</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,560</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,984</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,328</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,094</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,633</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,492</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,161</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,272</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,193</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,476</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,489</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,272</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,193</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,476</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,489</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expense, net</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(254</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(313</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,485</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(287</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,526</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,506</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33,961</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,776</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit (expense)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,521</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,523</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33,940</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,758</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per common share</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; outstanding</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.28</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.52</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.49</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.81</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.76%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares used in net</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; loss per share attributable to common</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; stockholders, basic and diluted</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,113,457</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,425,770</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,841,481</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,059,011</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Investor Contact</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Katie McManus</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trevi Therapeutics, Inc.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203-304-2499</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">k.mcmanus@trevitherapeutics.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Media Contact</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rosalia Scampoli</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">914-815-1465</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rscampoli@marketcompr.com</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g3zsz0wdgmtp000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3zsz0wdgmtp000001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $H >\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHIXQ+!(KJW*LIR#2'<=11D=<T9% !1110 4444 %%%% !1110 4444 %%%%
M!2%EZ9I:_/\ _P"#C3X]?&K]G;]B3P_XW^!'Q4U[PCK$_P 1+.TFU+P_J4EK
M,\#6EXS1ED()4LBDCIE1Z5TX/#2QF*A0B[.3M<Y,?C(8#!SQ$U=15[(_0#</
M6C</6OY3Q_P5/_X*1X_Y/C^)_P#X6%U_\71_P]/_ ."D?_1\?Q/_ /"PNO\
MXNOJ/]3<9_S]C^)\9_Q$#+_^?,OO1_5AN'K1N7UK^4__ (>G_P#!2/\ Z/C^
M)_\ X6%U_P#%UZE^P]_P4E_;_P#'/[:'PE\%^,?VR/B-J>DZM\2-%L]3TZ\\
M57,D-U;R7T*21.I;#*RD@@\$&HJ<(8NG3<W4CHF^O0TH\>8&M6C35*6K2Z==
M#^EX'/2B@# P**^1/N@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .5^.B*WP4\8
M;E_YE74/_2:2OYJ8[*W)P8(_KL%?TL?''GX*^,!_U*^H?^DTE?S90Q@* !7Z
M%P.[4J_K']3\I\2(\V(PWI+\XC(K.V4#%NG_ 'P.:GBL83Q]G3_O@5)%!S5F
M./\ A1:^ZN?FZ78ACLK8?*(%]/N"OWQ_X)GP*W[ GPSMXV,>?#*C='P5_>/R
M*_!N*+)X_.OWI_X)HKC]@_X9+_U+:_\ HQZ^+XT_W"G_ (OT9^A>'L;9E5_P
M?^W(ZT1>/$\!ZJVF^)M2_M)_$GV2QN+J-7\J$7XC5MNSE3&?F..1SD=:O> O
M$_C'Q/XR_M+5[&YL=/FTEEBT^:' CFCD17<DC.XNTJCG!2-6'WLUW&VC:,YK
M\W/UKE\Q111104%%%% !1110 4444 %%%% !1110 5^:?_!TU_RC[\-_]E0L
M?_2*^K]+*_-/_@Z:_P"4??AO_LJ%C_Z17U>KD?\ R-J/^)'B<2?\B.O_ (3^
M?\=**!THK]?/P8*]A_X)Z9_X;U^"Q_ZJIH'_ *<(*\>SDXQ7L7_!/08_;T^"
MX _YJGH'_IPAK'%?[M/T?Y'5@?\ ?*7^*/YH_K*HH%%?B)_104444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% '+_'#_DBWB_/_ $*^H?\ I-)7\W<,61U_&OZ:+NTM
MK^VDLKVWCFAE0I-#(H974C!4@\$$=1WKCO\ AFS]G4=/@%X*_P#"5M/_ (W7
MTF0Y[3R>%2,H.7-;9VM:_P#F?(\3<-5,_J4I0J*'(FM5>][>?D?SH)'NJ>-"
M>*_HI_X9N_9V_P"B!^"__"5M/_C='_#-_P"SO_T03P7_ .$M:?\ QNO>_P!=
MJ/\ SY?WK_(^97AWB%_S$+_P%_YG\[T4848K]X_^":8V_L)?#,?]2VO_ *,>
MN^/[-_[/';X#>"__  E[3_XW75:'H>C>&M*AT+P]I%K865LNRWL[*W6**)?1
M44 */8"O$SSB"GFV'C3C3<;.^KOT:_4^DX=X8J9'BIUI5%+FC:R5NJ??R+5%
M%%?,'V 4444 %%%% !1110 4444 %%%% !1110!CZY\0_ /A>]73?$WC?2--
MN&C$BV]_J44+E22 VUV!QD'GVK\T_P#@Y\^('@3Q5^P/X<T_POXUTG4KA?B=
M8NT-AJ44SA?L5Z-V$8G&2.?>OCG_ (.D%"_\%%M!P/\ FE>F_P#I=?U^;IZ<
MU]YD?#T?W.-]IV=K?A>_Z'YGQ'Q5+FQ&7>R[QYN;\;6_40'C.*4$,=M  QBG
M*H/'\/\ .ON#\W!%ST/'>O8/V +FUT_]N?X.7]]<QP6\/Q0T)YIIG"K&HOX2
M68G@ #J37D:KGM4B)VI5*?M*<H]TU]X4JWL:T:F]FG]S/Z_A\9/A#CCXJ^&_
M_!Y;_P#Q=!^,GPA _P"2J>&__!Y;_P#Q=?R#JNT8 IRID<BOC/\ 4F'_ #_?
M_@/_  3] _XB14_Z!E_X'_\ :G]BUI=VU];1WME.DT,R!XI8V#*ZD9!!'!!'
M>OFS_@J]^V]XW_X)]_LJ']H+P!X-TO7K]?$EGIOV#6))$AV3"3+YC(;<-@QS
MCFO3?V,5"_L@?"M0/^:<Z)_Z00U\C?\ !RUS_P $U9!_U/VD_P IZ^2RW#TZ
MF;4Z-17BY6?FKGW>;8NM2R*KB:3Y9*',GV=KGQX/^#J?]J'_ *-B\!?^!U[_
M /%T'_@ZF_:AQ_R;'X"_\#;W_P"+K\LQ@=*O:5H&M:T_E:1I%U=N>BV]NTA/
M_?(-?I_^KN2_\^5][_S/Q3_6[B3IB']R_P C]01_P=1?M/GD_LR> O\ P-O?
M_CE>E_L=?\'%_P"T-^TI^U+X#^ GB/X >#=-L?%WB:VTRZOK&ZNVF@CD;!9
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MVT^3/SCCS.N)\BSSDP^(DJ51*459:=&M5T:OZ-'Z6I_P<R?M*-_S;CX']O\
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M_9_\&_\ @9=__%U(G_!P_P#M"2?\T!\&C_M[N_\ XNOSUA@)Y?\ _55B./\
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M>WEZ,HY609^ZPZ$?Y&*]*IA8WYJ;Y7^!Y='%RY>2JN:/X_U_5S2\<_"?Q/X
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MHE+]#!2/(VJ*L11A12H@4<5/# 2>17VQ^?V[!% 7.:_:S_@GJ,?L7?#P#_H
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MY<._E8_[L2^D4:XSC!<\G!;CYUGN/$/CCQ(+B]N);[4=1N%4-(<L[L< >PZ
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M&LD+AD8!E93D,#T(]17RW^U-H%SI/Q?NK^0?N]2M8;B-OH@C(_./]17G9?\
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M (*'W7Q.\"^&_A/^T%K&WQ)+IMO'I6OW4G_(4.P ),QZ3GLQ_P!83@_/]_\
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MKYTU/2QI>L7>E_\ /M=21?\ ?+$?TKZ41 !TKY_\7A)?&.K2QCY?[2GQCO\
MO#7TV!;YI(^1S**Y8F7#!CFOV0_8(&/V// (Q_S E_\ 0VK\>8H=W.*_8C]@
MWC]D'P$,?\P-?_0VKQ>+G_L5/_%^C/H."(VQ]1_W?U1ZY1117Y^?I@4444 %
M%%% !1110 4444 %%%% !1110 4$9&*** /@G_@M#_P2*M?V[O"L?QI^"L%O
M9_%+P]8^3#'(RQQ>(+1<L+61S@)*I)\J0G'S%&PI#)^!/C/P1XQ^&_BN_P#
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M6WU31?!^FV&HVZR*XCGAM8XY%#*2&PRD9!(/:O ?^"SG[+7QH_;!_8U;X/?
M;PU#JVO'Q587WV6?4(K9?)B$N]M\K*O&X<9R:_)\OJ48YW3G-KEY[MO:U^Y^
M_9Q1Q,N%ZM.E%N?L[)):WMLEW/Q6L?B=\(?V@/#_ /PB?C+&F7C-NCCN9@NR
M3'WH9<;2>V#@GI@BO,OB7\ /&?PZ=[Z"W;4M+'*WULG*+_TT3DK]>5]^U?2
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MO_(^?8H<#(K]@/V$@5_9$\!@_P#0#7_T-J^!X_\ @F)^V*OS'X<VG_@\M?\
MXY7Z(_LJ>!/$WPR_9Y\*^ ?&5BMMJFEZ8(;R!95D"/N8XW*2#U[&O%XFQF%Q
M&$A&E-2?-T:?1GT/"6!QF%QDY5J<HIQZIKJNYZ#1117Q)]\%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !117-_$'XP_"SX4?9?\
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M8M-?>M :<=&%%%%;""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"W2/]E7QQ;I]V/PW,%_!:\K_ ."3:@?LZ:HV?^9NN!_Y+VU>K?MC@M^RWXZ
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M97*R>Y4&OU-C<.@=6R#SD=Z^6/VX/V:-*L?V+M+T7PQ:JTWP\AMYH9%CR\L
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MF6*R^A.A@*G)[.,TXIS4??E"+U47]ST72RBO+W8J3NS\\?\ @GG^S/\ "O\
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M[7"A/V7O'2C^'PO=?^BS7:>#MO\ PB.EE!\O]FP8S_US%<7^UT,_LP^.^/\
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MW?L6****^\, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>trvi-20220317.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-01-04T02:56:02.0803877+00:00 -->
<!-- Version            : 5.0.1.702 -->
<!-- Package ID         : 00a6edb0ee1c494c9c06a5b6abb60fa0 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:trvi="http://www.trevitherapeutics.com/20220317" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.trevitherapeutics.com/20220317" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" namespace="http://xbrl.sec.gov/currency/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" namespace="http://xbrl.sec.gov/exch/2021" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" namespace="http://xbrl.sec.gov/sic/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" namespace="http://fasb.org/srt-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" namespace="http://fasb.org/srt-types/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" namespace="http://fasb.org/us-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.trevitherapeutics.com/20220317/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="trvi-20220317_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="trvi-20220317_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>trvi-20220317_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-01-04T02:56:02.0803877+00:00 -->
<!-- Version            : 5.0.1.702 -->
<!-- Package ID         : 00a6edb0ee1c494c9c06a5b6abb60fa0 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>trvi-20220317_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-01-04T02:56:02.0803877+00:00 -->
<!-- Version            : 5.0.1.702 -->
<!-- Package ID         : 00a6edb0ee1c494c9c06a5b6abb60fa0 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.trevitherapeutics.com/20220317/role/TemplateLink" xlink:href="trvi-20220317.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="trvi-20220317.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139662756303240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 17, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001563880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 17,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Trevi Therapeutics,&#160;Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-0834299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">195 Church Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">14th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New Haven<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">304-2499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TRVI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>trvi-8k_20220317_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="trvi-20220317.xsd" xlink:type="simple"/>
    <context id="C_0001563880_20220317_20220317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001563880</identifier>
        </entity>
        <period>
            <startDate>2022-03-17</startDate>
            <endDate>2022-03-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001563880_20220317_20220317" id="F_000000">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001563880_20220317_20220317" id="F_000001">0001563880</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001563880_20220317_20220317" id="F_000002">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001563880_20220317_20220317" id="F_000003">2022-03-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001563880_20220317_20220317" id="F_000004">Trevi Therapeutics,&#160;Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001563880_20220317_20220317" id="F_000005">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001563880_20220317_20220317" id="F_000006">001-38886</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001563880_20220317_20220317" id="F_000007">45-0834299</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001563880_20220317_20220317" id="F_000008">195 Church Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001563880_20220317_20220317" id="F_000009">14th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001563880_20220317_20220317" id="F_000010">New Haven</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001563880_20220317_20220317" id="F_000011">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001563880_20220317_20220317" id="F_000012">06510</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001563880_20220317_20220317" id="F_000013">(203)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001563880_20220317_20220317" id="F_000014">304-2499</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001563880_20220317_20220317" id="F_000015">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001563880_20220317_20220317" id="F_000016">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001563880_20220317_20220317" id="F_000017">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001563880_20220317_20220317" id="F_000018">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001563880_20220317_20220317" id="F_000019">Common stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001563880_20220317_20220317" id="F_000020">TRVI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001563880_20220317_20220317" id="F_000021">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001563880_20220317_20220317" id="F_000022">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_0001563880_20220317_20220317" id="F_000023">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M'H#?ETK90\,=WLO_7H;_ E!+ P04    " #H@'%4GZ ;\+$"  #B#   #0
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M/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #H@'%4!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .B
M<53.[_O_[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( .B <5297)PC$ 8  )PG   3              "
M <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ Z(!Q5']V\9%U
M!   AQ$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( .B <52?H!OPL0(  .(,   -              "
M ;@,  !X;"]S='EL97,N>&UL4$L! A0#%     @ Z(!Q5)>*NQS     $P(
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9>&UL4$L%!@     )  D /@(  !@4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="trvi-8k_20220317.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="trvi-8k_20220317.htm">trvi-8k_20220317.htm</File>
    <File>trvi-20220317.xsd</File>
    <File>trvi-20220317_lab.xml</File>
    <File>trvi-20220317_pre.xml</File>
    <File>trvi-ex991_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "trvi-8k_20220317.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "trvi-8k_20220317.htm"
     ]
    },
    "labelLink": {
     "local": [
      "trvi-20220317_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "trvi-20220317_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "trvi-20220317.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "trvi",
   "nsuri": "http://www.trevitherapeutics.com/20220317",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "trvi-8k_20220317.htm",
      "contextRef": "C_0001563880_20220317_20220317",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "trvi-8k_20220317.htm",
      "contextRef": "C_0001563880_20220317_20220317",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20220317/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-22-010864-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-010864-xbrl.zip
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MGW'VU@^* B0<ML1>HSK;IHI-"I/JXIH(ZA N^J%<,.$Q3MX-K)/:0I F A>
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M7,N3 ;OH=GV7NP-45BS]2#/9!:!->WW0E9>Z"/=XJW>>+V.N^[[+/J=!"!P
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M). AF4@!1FZ$=C)+(X9%)/NW&$S.:ZAU,8#GWS(3[?VX%XBNWH./M$'3CDP
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M0&(8QQ8"TF6C8_*K8GPX$<XM[%<SX\#E_:I ^K/<JEX;C;(>Y59/BAV+@Y5
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MT.!><6*=[.E=F3=:7]+S-I#=7A]TI#= DCOHZS" %_\/4$L! A0#%     @
MZ(!Q5 D"X!.Y!   AA8  !$              ( !     '1R=FDM,C R,C S
M,3<N>'-D4$L! A0#%     @ Z(!Q5#U:,FE2!P  W$X  !4
M ( !Z 0  '1R=FDM,C R,C S,3=?;&%B+GAM;%!+ 0(4 Q0    ( .B <50'
MR(KI(P4  /0N   5              "  6T,  !T<G9I+3(P,C(P,S$W7W!R
M92YX;6Q02P$"% ,4    " #H@'%4O-"7[7P1  #JI0  %
M@ '#$0  =')V:2TX:U\R,#(R,#,Q-RYH=&U02P$"% ,4    " #H@'%4<=YR
MY_0>   @+@( $               @ %Q(P  =')V:2UE>#DY,5\V+FAT;5!+
4!08     !0 % $4!  "30@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
